{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:32:28Z","timestamp":1790087548223,"version":"4.0.1"},"reference-count":104,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs and digestive system. Over the years, advancements in medical care and treatments have significantly increased the life expectancy of individuals with CF. However, with this improved longevity, concerns about the potential risk of developing certain types of cancers have arisen. This narrative review aims to explore the relationship between CF, increased life expectancy, and the associated risk for cancers. We discuss the potential mechanisms underlying this risk, including chronic inflammation, immune system dysregulation, and genetic factors. Additionally, we review studies that have examined the incidence and types of cancers seen in CF patients, with a focus on gastrointestinal, breast, and respiratory malignancies. We also explore the impact of CFTR modulator therapies on cancer risk. In the gastrointestinal tract, CF patients have an elevated risk of developing colorectal cancer, pancreatic cancer, and possibly esophageal cancer. The underlying mechanisms contributing to these increased risks are not fully understood, but chronic inflammation, altered gut microbiota, and genetic factors are believed to play a role. Regular surveillance and colonoscopies are recommended for early detection and management of colorectal cancer in CF patients. Understanding the factors contributing to cancer development in CF patients is crucial for implementing appropriate surveillance strategies and improving long-term outcomes. Further research is needed to elucidate the molecular mechanisms involved and develop targeted interventions to mitigate cancer risk in individuals with CF.<\/jats:p>","DOI":"10.3390\/cancers15174244","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:23:40Z","timestamp":1692872620000},"page":"4244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-0195","authenticated-orcid":false,"given":"Giuseppe Fabio","family":"Parisi","sequence":"first","affiliation":[{"name":"Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-2374","authenticated-orcid":false,"given":"Maria","family":"Papale","sequence":"additional","affiliation":[{"name":"Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pecora","sequence":"additional","affiliation":[{"name":"Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novella","family":"Rotolo","sequence":"additional","affiliation":[{"name":"Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-8411","authenticated-orcid":false,"given":"Sara","family":"Manti","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Human and Pediatric Pathology \u201cGaetano Barresi\u201d, AOUP G. Martino, University of Messina, Via Consolare Valeria, 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-7473","authenticated-orcid":false,"given":"Giovanna","family":"Russo","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-6400","authenticated-orcid":false,"given":"Salvatore","family":"Leonardi","sequence":"additional","affiliation":[{"name":"Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"106623","DOI":"10.1016\/j.rmed.2021.106623","article-title":"Combined use of rheology and portable low-field NMR in cystic fibrosis patients","volume":"189","author":"Abrami","year":"2021","journal-title":"Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: Advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Scott, P., Wang, S., Onyeaghala, G., Pankratz, N., Starr, T., and Prizment, A.E. (2023). Lower Expression of CFTR Is Associated with Higher Mortality in a Meta-Analysis of Individuals with Colorectal Cancer. Cancers, 15.","DOI":"10.3390\/cancers15030989"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bhattacharya, R., Blankenheim, Z., Scott, P.M., and Cormier, R.T. (2022). CFTR and Gastrointestinal Cancers: An Update. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060868"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Scott, P., Anderson, K., Singhania, M., and Cormier, R. (2020). Cystic Fibrosis, CFTR, and Colorectal Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082891"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e14568","DOI":"10.1016\/j.heliyon.2023.e14568","article-title":"CFTR High Expresser Cells in cystic fibrosis and intestinal diseases","volume":"9","author":"Dastoor","year":"2023","journal-title":"Heliyon"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-023-02671-z","article-title":"Increasing incidence rate of breast cancer in cystic fibrosis\u2014Relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens","volume":"18","author":"Stastna","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s43042-022-00308-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR): Beyond cystic fibrosis","volume":"23","author":"Parisi","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moliteo, E., Sciacca, M., Palmeri, A., Papale, M., Manti, S., Parisi, G.F., and Leonardi, S. (2022). Cystic Fibrosis and Oxidative Stress: The Role of CFTR. Molecules, 27.","DOI":"10.3390\/molecules27165324"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: From molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yu, C., and Kotsimbos, T. (2023). Respiratory Infection and Inflammation in Cystic Fibrosis: A Dynamic Interplay among the Host, Microbes, and Environment for the Ages. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044052"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1165\/rcmb.2019-0107ED","article-title":"Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?","volume":"61","author":"Murphy","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, B., Sodji, Q.H., and Oyelere, A.K. (2022). Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers, 14.","DOI":"10.3390\/cancers14030552"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13256-021-03234-1","article-title":"Malignancies in patients with cystic fibrosis: A case series","volume":"16","author":"Appelt","year":"2022","journal-title":"J. Med. Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tam, R.Y., van Dorst, J.M., McKay, I., Coffey, M., and Ooi, C.Y. (2022). Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030649"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chest.2021.09.003","article-title":"Cancer in Cystic Fibrosis: A Narrative Review of Prevalence, Risk Factors, Screening, and Treatment Challenges: Adult Cystic Fibrosis Series","volume":"161","author":"Maisonneuve","year":"2022","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hanssens, L.S., Duchateau, J., and Casimir, G.J. (2021). CFTR Protein: Not Just a Chloride Channel?. Cells, 10.","DOI":"10.3390\/cells10112844"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Farinha, C.M., and Gentzsch, M. (2021). Revisiting CFTR Interactions: Old Partners and New Players. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413196"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/cr.2012.88","article-title":"CFTR mediates bicarbonate-dependent activation of miR-125b in preimplantation embryo development","volume":"22","author":"Lu","year":"2012","journal-title":"Cell Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00018-018-2755-6","article-title":"Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer","volume":"75","author":"Zhang","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jcf.2022.12.015","article-title":"Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy","volume":"22","author":"Ghigo","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lukasiak, A., and Zajac, M. (2021). The Distribution and Role of the CFTR Protein in the Intracellular Compartments. Membranes, 11.","DOI":"10.3390\/membranes11110804"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.chest.2018.10.006","article-title":"The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease","volume":"155","author":"Liou","year":"2019","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4149\/neo_2017_508","article-title":"Knockdown of CFTR enhances sensitivity of prostate cancer cells to cisplatin via inhibition of autophagy","volume":"64","author":"Zhu","year":"2017","journal-title":"Neoplasma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","article-title":"TNFalpha blockade in human diseases: Mechanisms and future directions","volume":"126","author":"Wong","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","article-title":"Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome","volume":"137","author":"Yang","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Strandvik, B. (2022). Nutrition in Cystic Fibrosis-Some Notes on the Fat Recommendations. Nutrients, 14.","DOI":"10.3390\/nu14040853"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2006030269","article-title":"Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney","volume":"18","author":"Jouret","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1245\/s10434-021-09752-y","article-title":"Expression and Role of CFTR in Human Esophageal Squamous Cell Carcinoma","volume":"28","author":"Matsumoto","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/s41598-022-05922-4","article-title":"Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma","volume":"12","author":"Shi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2018.11.005","article-title":"Cystic fibrosis is associated with an increased risk of Barrett\u2019s esophagus","volume":"18","author":"Knotts","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E226","DOI":"10.25011\/cim.v37i4.21728","article-title":"Predictive value of cystic fibrosis transmembrane conductance regulator (CFTR) in the diagnosis of gastric cancer","volume":"37","author":"Liu","year":"2014","journal-title":"Clin. Investig. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: A systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.trecan.2023.04.012","article-title":"The conundrum of Helicobacter pylori-associated apoptosis in gastric cancer","volume":"9","author":"Lim","year":"2023","journal-title":"Trends Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12767","DOI":"10.3748\/wjg.v20.i36.12767","article-title":"Effect of Helicobacter pylori on gastric epithelial cells","volume":"20","author":"Alzahrani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4251\/wjgo.v8.i3.282","article-title":"Emerging role of cystic fibrosis transmembrane conductance regulator\u2014An epithelial chloride channel in gastrointestinal cancers","volume":"8","author":"Hou","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.3748\/wjg.v25.i38.5732","article-title":"Role of ion channels in gastrointestinal cancer","volume":"25","author":"Anderson","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Patergnani, S., Danese, A., Bouhamida, E., Aguiari, G., Previati, M., Pinton, P., and Giorgi, C. (2020). Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218323"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1074\/jbc.C109.000869","article-title":"Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated Cl- secretory channel in mouse airways","volume":"284","author":"Rock","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/gut.2007.125278","article-title":"Risk of pancreatic cancer in patients with cystic fibrosis","volume":"56","author":"Maisonneuve","year":"2007","journal-title":"Gut"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.24697","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma","volume":"116","author":"McWilliams","year":"2010","journal-title":"Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","article-title":"Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice","volume":"11","author":"Guerra","year":"2007","journal-title":"Cancer Cell."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pan.2012.06.002","article-title":"The burning question: Why is smoking a risk factor for pancreatic cancer?","volume":"12","author":"Pandol","year":"2012","journal-title":"Pancreatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/MPA.0000000000001145","article-title":"Pancreatitis-Associated Genes and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis","volume":"47","author":"Cazacu","year":"2018","journal-title":"Pancreas"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.2730","article-title":"Variants in CPA1 are strongly associated with early onset chronic pancreatitis","volume":"45","author":"Witt","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"102675","DOI":"10.1016\/j.ebiom.2020.102675","article-title":"A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants","volume":"53","author":"Earl","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/eji.201848009","article-title":"Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells","volume":"49","author":"Luu","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"114586","DOI":"10.1016\/j.biopha.2023.114586","article-title":"Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides","volume":"162","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e11215","DOI":"10.5812\/hepatmon.11215","article-title":"Liver disease in cystic fibrosis: An update","volume":"13","author":"Parisi","year":"2013","journal-title":"Hepat. Mon."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis-associated liver cirrhosis: Management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"G459","DOI":"10.1152\/ajpgi.00146.2014","article-title":"Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: Gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology","volume":"308","author":"Olivier","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00042737-200510000-00018","article-title":"Advanced hepatocellular carcinoma associated with cystic fibrosis","volume":"17","author":"Kelleher","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2004.04.006","article-title":"Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis","volume":"3","author":"McKeon","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/jhep.2000.9111","article-title":"Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis","volume":"32","author":"Kinnman","year":"2000","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ijc.24394","article-title":"Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma","volume":"125","author":"Moribe","year":"2009","journal-title":"Int. J. Cancer."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.11.001","article-title":"Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity","volume":"19","author":"Paranjapye","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.etap.2015.08.033","article-title":"Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups","volume":"40","author":"Namgoong","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: A 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","article-title":"Chronic inflammation and oxidative stress in human carcinogenesis","volume":"121","author":"Federico","year":"2007","journal-title":"Int. J. Cancer."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3892\/mmr.2020.11744","article-title":"Wnt\/\u03b2-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review)","volume":"23","author":"Zhu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_68","first-page":"725710","article-title":"Oxidative stress in the pathogenesis of colorectal cancer: Cause or consequence?","volume":"2013","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/codi.16472","article-title":"A systematic review of the colorectal microbiome in adult cystic fibrosis patients","volume":"25","author":"Gilbert","year":"2023","journal-title":"Colorectal Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-021-00817-2","article-title":"The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis","volume":"23","author":"Karb","year":"2021","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Amaral, M.D., Quaresma, M.C., and Pankonien, I. (2020). What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093133"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"807648","DOI":"10.3389\/fimmu.2021.807648","article-title":"Potential Role of the Gut Microbiome In Colorectal Cancer Progression","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jcf.2017.06.013","article-title":"Cystic Fibrosis & disorders of the large intestine: DIOS, constipation, and colorectal cancer","volume":"16","author":"Abraham","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2147\/CMAR.S248539","article-title":"CFTR Functions as a Tumor Suppressor and Is Regulated by DNA Methylation in Colorectal Cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"BSR20181052","DOI":"10.1042\/BSR20181052","article-title":"A trial sequential meta-analysis of TNF-\u03b1 -308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer","volume":"39","author":"Mandal","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European Cystic Fibrosis Society Standards of Care: Best Practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/gidisord3020009","article-title":"Surveillance of Colorectal Cancer (CRC) in Cystic Fibrosis (CF) Patients","volume":"3","author":"Ingravalle","year":"2021","journal-title":"Gastrointest. Disorders."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/curroncol29020104","article-title":"Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management","volume":"29","author":"Gelsomino","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"000475","DOI":"10.1183\/23120541.00475-2020","article-title":"Sex disparities in cystic fibrosis: Review on the effect of female sex hormones on lung pathophysiology and outcomes","volume":"7","author":"Lam","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1092-9134(98)80019-1","article-title":"Breast abnormalities in patients with cystic fibrosis: Previously unrecognized changes","volume":"2","author":"Garcia","year":"1998","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/jpet.109.162032","article-title":"Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition","volume":"333","author":"Kelly","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/med.20131","article-title":"Estrogen and its receptors in cancer","volume":"28","author":"Chen","year":"2008","journal-title":"Med. Res. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/rccm.201001-0053OC","article-title":"17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor","volume":"182","author":"Chotirmall","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.bbamcr.2013.07.021","article-title":"Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer","volume":"1833","author":"Zhang","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jcf.2019.08.024","article-title":"Female reproductive health in cystic fibrosis","volume":"18","author":"Hughan","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"993540","DOI":"10.3389\/fonc.2023.993540","article-title":"The road to breast cancer screening with diffusion MRI","volume":"13","author":"Iima","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17843286.2020.1737780","article-title":"Lung cancer in a CF patient: Combination of bad luck or is there more to say?","volume":"76","author":"Vekens","year":"2021","journal-title":"Acta Clin. Belg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1043691","DOI":"10.3389\/fpubh.2022.1043691","article-title":"Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France","volume":"10","author":"Dalon","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2020.01438","article-title":"Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis","volume":"11","author":"Cabrini","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_92","first-page":"553","article-title":"Surface morphology of human airway mucosa: Normal, carcinoma or cystic fibrosis","volume":"2","author":"Jeffery","year":"1988","journal-title":"Scanning Microsc."},{"key":"ref_93","first-page":"101242","article-title":"Primary lung carcinoma in cystic fibrosis: A case report and literature review","volume":"31","author":"Patel","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/rccm.201304-0733OC","article-title":"Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function","volume":"188","author":"Raju","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/014107680109440s08","article-title":"Smoking and cystic fibrosis","volume":"94","author":"Verma","year":"2001","journal-title":"J. R. Soc. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3892\/ol.2011.479","article-title":"Association of CFTR gene polymorphisms with papillary thyroid cancer","volume":"3","author":"Oh","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: A global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic Fibrosis Modulator Therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Giallongo, A., Parisi, G.F., Papale, M., Manti, S., Mul\u00e9, E., Aloisio, D., Terlizzi, V., Rotolo, N., and Leonardi, S. (2023). Effects of Elexacaftor\/Tezacaftor\/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease. Genes, 14.","DOI":"10.3390\/genes14020449"},{"key":"ref_100","first-page":"3","article-title":"CFTR modulator therapies-Effect on life expectancy in people with cystic fibrosis","volume":"42","author":"King","year":"2022","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Dagenais, R.V.E., Su, V.C.H., and Quon, B.S. (2020). Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010023"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s41030-020-00115-8","article-title":"Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012-2016 Experience","volume":"6","author":"Higgins","year":"2020","journal-title":"Pulm. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S1569-1993(16)30206-5","article-title":"Real-world outcomes in patients (PTS) with cystic fibrosis (CF) treated with ivacaftor (IVA): Analysis of 2014 US and UK CF registries","volume":"15","author":"Bai","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S2213-2600(20)30517-8","article-title":"Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: A phase 3, open-label, extension","volume":"9","author":"Chilvers","year":"2021","journal-title":"Lancet Respir. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:38:25Z","timestamp":1760128705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":104,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15174244"],"URL":"https:\/\/doi.org\/10.3390\/cancers15174244","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}